Cellosaurus KOLF2.1J EIF2B1 V183F REV/REV (CVCL_E7KK)
| Cell line name | KOLF2.1J EIF2B1 V183F REV/REV |
|---|---|
| Synonyms | JIPSC001544 |
| Accession | CVCL_E7KK |
| Resource Identification Initiative | To cite this cell line use: KOLF2.1J EIF2B1 V183F REV/REV (RRID:CVCL_E7KK) |
| Comments | From: The Jackson Laboratory; Bar Harbor; USA. Population: Caucasian; British. Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited EIF2B1 p.Val183Phe (c.547G>T) cell line (JAX=JIPSC001544). Derived from site: In situ; Skin; UBERON=UBERON_0002097. Cell type: Fibroblast of skin; CL=CL_0002620. |
| Sequence variations |
|
| Disease | Leukoencephalopathy with vanishing white matter (NCIt: C122664) CACH syndrome (ORDO: Orphanet_135) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_E7KL (KOLF2.1J EIF2B1 V183F SNV/SNV) |
| Sex of cell | Male |
| Age at sampling | 55-59Y |
| Category | Induced pluripotent stem cell |
| Web pages | Provider; JAX; JIPSC001544; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001544 |
| Entry history | |
| Entry creation | 10-Apr-2025 |
| Last entry update | 10-Apr-2025 |
| Version number | 1 |